NI Nukkleus Inc. Stock: price and management transactions · United States · SEC (Form 4)Follow the Nukkleus Inc. share price and the full directors' dealings record of the company, a listed equity based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Operating in the Banks sector, Nukkleus Inc. has recorded 25 insider filings. The latest transaction was reported on 29 January 2026 (X). Among the most active insiders: Kotaieva Anastasiia. All data is accessible without an account.
€832,111
5 ops.
Sell Volume
Buys €1,562 €832,111 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 29 January 2026
All Executives25 Thresholds0 Prospectus0 Other0
Declarations 25 total
● CEO · Executives · 29 Jan 2026
200,000 shares @ US$1.50 27.5% of flow Common Stock $0.0001 par value per share SEC:0001213900-26-009491:0
● CEO · Executives · 16 Jan 2026
1,992,010 shares 0Common Stock$0.0001 par value per share SEC:0001213900-26-005839:0
30,000 shares @ US$4.4146 8.8% of flow Common Stock, $0.0001 par value per share SEC:0001213900-25-126863:0
75,000 shares @ US$4.0902 20.3% of flow Common Stock, $0.0001 par value per share SEC:0001213900-25-127149:0
30,000 shares @ US$4.4146 8.8% of flow Common Stock, $0.0001 par value per share SEC:0001213900-25-126147:0
38,744 shares @ US$4.7222 12.1% of flow Common Stock, $0.0001 par value per share SEC:0001213900-25-124543:0
◆ Director · Executives · 13 Nov 2025
5,000 shares 0Common Stock, $0.0001 par value per share SEC:0001213900-25-113015:0
◆ Director · Executives · 13 Nov 2025
10,000 shares 0Common Stock, $0.0001 par value per share SEC:0001213900-25-113013:0
◆ Director · Executives · 13 Nov 2025
5,000 shares 0Common Stock, $0.0001 par value per share SEC:0001213900-25-113009:0
◆ Director · Executives · 13 Nov 2025
5,000 shares 0Common Stock, $0.0001 par value per share SEC:0001213900-25-113008:0
◆ Chief Executive Officer · Executives · 13 Nov 2025
750,000 shares 0Common Stock, $0.0001 par value per share SEC:0001213900-25-111632:0
● Director · Executives · 24 Oct 2025
377,432 shares 0Common Stock, $0.0001 par value per share SEC:0001213900-25-102188:0
▲ Director · Executives · 8 Oct 2025
117,568 shares Common Stock, $0.0001 par value per share SEC:0001213900-25-098218:0
Canonical exit: 6 Jan 2026 (T+90) ◆ Chief Executive Officer · Executives · 16 Dec 2024
150,000 shares @ US$1.39 9.2% of flow Common Stock, $0.0001 par value per share SEC:0001213900-24-111518:0
◆ Chief Executive Officer · Executives · 16 Dec 2024
500,000 shares @ US$1.39 100.0% of flow Common Stock, $0.0001 par value per share SEC:0001213900-24-111169:0
◆ Chief Executive Officer · Executives · 16 Dec 2024
10,000 shares @ US$1.39 100.0% of flow Common Stock, $0.0001 par value per share SEC:0001213900-24-111168:0
◆ Chief Executive Officer · Executives · 16 Dec 2024
10,000 shares @ US$1.39 100.0% of flow Common Stock, $0.0001 par value per share SEC:0001213900-24-111170:0
◆ Chief Executive Officer · Executives · 16 Dec 2024
10,000 shares @ US$1.39 100.0% of flow Common Stock, $0.0001 par value per share SEC:0001213900-24-111166:0
◆ Chief Executive Officer · Executives · 16 Dec 2024
500,000 shares @ US$1.39 30.8% of flow Common Stock, $0.0001 par value per share SEC:0001213900-24-111167:0
● Chief Executive Officer · Executives · 20 Nov 2023
157,500,000 shares Common Stock, $0.0001 par value per share SEC:0001213900-23-089908:0
▼ Chief Executive Officer · Executives · 16 Oct 2023
4,000,000 shares @ US$0.05 98.4% of flow Common Stock, $0.0001 par value per share SEC:0001013762-23-004472:0
● Chief Operating Officer · Executives · 7 Jun 2023
6,600,000 shares Common Stock, $0.0001 par value per share SEC:0001213900-23-047512:0
▲ Chief Operating Officer · Executives · 30 Aug 2021
11,119,792 shares Common Stock, $0.0001 par value per share SEC:0001213900-22-008266:0
Canonical exit: 28 Nov 2021 (T+90) ● Chief Executive Officer · Executives · 3 Feb 2022
1,000,000 shares Common Stock, $0.0001 par value per share SEC:0001213900-22-008265:0
▲ Chief Executive Officer · Executives · 4 Aug 2021
15,000 shares @ US$0.1233 0.8% of flow Common Stock, $0.0001 par value per share SEC:0001213900-21-041205:0
Canonical exit: 2 Nov 2021 (T+90) 关于 Nukkleus Inc. Nukkleus Inc. 是一家在美国纳斯达克(NASDAQ)上市的公司,在过去几个季度经历了显著的战略转型。历史上,该公司与金融科技、数字资产执行、多资产交易技术以及法币到加密货币支付通道相关联。最近,管理层已将业务重新定位到航空航天和国防领域,采用收购主导模式来构建专业工业资产组合。对于投资者而言,这种转变很重要:股权故事不再主要围绕传统的金融科技敞口,而是关于公司能否执行以国防为重点的整合战略。([nukk.com](https://www.nukk.com/news/nukkleus-inc-acquires-london-based-match-financial-limited/?utm_source=openai))
该公司早期的商业模式以金融科技服务为中心,包括机构交易基础设施、流动性获取、加密相关执行和全球支付。这一传统仍然很重要,因为它解释了 Nukkleus 的核心运营方式:识别利基能力,收购它们,并尝试通过技术、分销和资本市场准入来扩大规模。然而,随着时间的推移,该公司扩大了其抱负,并开始将自己定位为高增长航空航天和国防业务的战略收购者和开发者。([nukk.com](https://www.nukk.com/news/nukkleus-inc-acquires-london-based-match-financial-limited/?utm_source=openai))
其当前的核心举措集中在国防相关垂直领域。Nukkleus 宣布成立 Nukkleus Defense Technologies,随后强调与 BladeRanger 签订了无人机有效载荷解决方案的独家美国分销协议。该公司还披露了对 Tiltan Software Engineering 的收购,该公司被描述为一家以色列开发商,专注于合成国防数据生成、GPS 拒止导航解决方案以及硬件在环/软件在环模拟器系统。总而言之,这些公告表明其专注于利基关键任务技术,而非广泛的制造。([globenewswire.com](https://www.globenewswire.com/news-release/2025/08/26/3139444/0/en/nukkleus-launches-defense-subsidiary-and-secures-exclusive-u-s-distribution-agreement-with-bladeranger-to-capitalize-on-booming-drone-payload-market.html?utm_source=openai))
从竞争角度来看,Nukkleus 仍然是一家小型、转型阶段的公司,在国防供应商、技术集成商和收购平台的碎片化市场中竞争。其潜在优势在于资本配置纪律、交易来源以及将软件、模拟、无人机相关有效载荷和分销整合到统一国防平台的能力。其劣势同样明显:整合风险、融资依赖以及在国防领域相对较短的运营记录。该公司本身在最近的沟通中已指出执行、资本和市场采纳风险。([globenewswire.com](https://www.globenewswire.com/news-release/2026/01/22/3224263/0/en/nukkleus-inc-provides-updates-on-acquisitions-and-outlines-its-2026-growth-strategy.html?utm_source=openai))
从地理上看,Nukkleus 是一家美国公司,其 SEC 文件显示其主要执行办公室位于新泽西州泽西城。该集团最近的交易活动也表明其具有国际足迹,包括以色列的国防相关资产和此前与英国相关的金融科技业务。这种全球混合为公司提供了选择性,但也增加了投资者评估治理、执行和战略一致性的复杂性。对于法国、比利时和瑞士的投资者而言,关键在于 Nukkleus 是一家正在转型中的纳斯达克上市公司,其近期新闻主要围绕收购、重组以及正式向国防领域转型。([sec.gov](https://www.sec.gov/Archives/edgar/data/1787518/000121390025011694/0001213900-25-011694-index.htm?utm_source=openai))